Scientists from the University of California, Irvine, the University of Michigan and the University of Texas MD Anderson Cancer Center have made a significant contribution to the field of pancreatic cancer research. Their ...
Apr 13, 2023
0
25
Scientists at VCU Massey Cancer Center discovered that the deletion of a specific protein creates a hostile environment for tumor cells and significantly subdues breast cancer growth and spread.
Apr 12, 2023
0
3
A new review paper was published in the journal Oncotarget on March 31, 2023, titled "Crosstalk between triple negative breast cancer and microenvironment."
Apr 11, 2023
0
5
A recent review paper published in the journal Cancers highlights the important role of the growth factor progranulin in the initiation and progression of cancer.
Mar 31, 2023
0
6
Researchers at Oregon State University have created a means of speeding up and improving the evaluation process for drugs used to combat cervical cancer.
Mar 31, 2023
0
19
Cancer-associated fibroblasts (CAFs) are key factors in the tumor microenvironment, which have been implicated in cancer cell progression. It has also been reported that vesicles called exosomes produced by these CAFs play ...
Mar 28, 2023
0
2
Fibroblasts build and maintain the extracellular matrix, or physical scaffolding for cells, in the connective tissues within the body. It is believed that cancerous tumors can recruit nearby fibroblasts and use them to promote ...
Mar 28, 2023
0
5
Sometimes research takes scientists to unexpected places, even alpaca farms. Tobiloba Oni is one of two Valhalla Fellows at Whitehead Institute who are researching ways to harness our natural defenses to combat cancer, an ...
Jan 18, 2023
0
2
Radiotherapy (RT) is a primary method of tumor treatment. However, in clinical practice, radiotherapy still suffers from shortcomings such as serious side effects, limited efficacy, and tumor metastasis and recurrence due ...
Jan 10, 2023
0
2
A new multidrug treatment for patients with stage IV melanoma has proven effective after a three-year clinical trial at the University of Colorado Cancer Center.
Dec 16, 2022
0
29
